News
For the most up to date news, please follow us on LinkedIn via the link below
Ghent University scientists launch CEPI-funded project ‘spin-freezing’ vaccines
March 11, 2024
Ghent University will receive up to US $1.9 million to test the performance of optimised mRNA vaccines, developed on the university’s specialised mRNA Galsomes platform, in preclinical models after ‘spin-freezing’ the vaccines. Pioneered by RheaVita, a spin-off company of Ghent University, spin-freezing is a novel alternative to the traditional freeze-drying method. The research will be supported by Flanders Institute for Biotechnology (VIB).
Download the White Paper describing how continuous aseptic freeze-drying can address the major pain points of pharmaceutical batch freeze-drying
February 14, 2024
We have created a White Paper describing how continuous aseptic freeze-drying can address the major pain points of pharmaceutical batch freeze-drying such as: time-consuming, inefficient, energy-consuming, and poorly controlled.
Download the White Paper on “Stabilizing mRNA LNPs via controlled, continuous freeze-drying”
February 9, 2024
Download the White Paper describing the advantages associated with a RheaVita’s NextGen continuous and controlled lyophilization.
Coriolis Pharma and RheaVita join forces in collaboration for continuous and controlled freeze-drying technology
July 31, 2023
Coriolis Pharma extends its service portfolio by integrating RheaVita’s single vial unit (SVU) technology for continuous and controlled freeze-drying to stabilize novel modalities as part of biologics drug product development for clients.
Continuous freeze-drying of mRNA LNPs enables storage at higher temperatures
March 31, 2023
Research at Ghent University, in collaboration with The University of British Columbia, has shown that continuous freeze-drying of mRNA LNPs enables long-term storage at higher temperatures for months without losing their transfection properties
Advanced Therapies – March 14 – 15, 2023
March 17, 2023
On March 14 & 15 we attended the Advanced Therapies Congress in London where we presented a new poster on avoiding cold chain logistic challenges by using freeze-drying to stabilize gene therapies.